Collagen Solutions PLC Exhibiting at 18th ESSKA conference

TIDMCOS

Collagen Solutions PLC

08 May 2018

8 May 2018

Collagen Solutions plc

("Collagen Solutions" or the "Company")

Collagen Solutions to Exhibit at 18(th) ESSKA Conference

"European Society of Sports Traumatology, Knee Surgery and Arthroscopy"

Dates: 9-12 May, SEEC, Glasgow

Collagen Solutions Plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, confirms that it will be exhibiting at the prestigious ESSKA conference being held in Glasgow between 9-12 May.

The ESSKA Congress, held every two years, is a major event in the pan-European calendar that brings together leading medical specialists, including orthopaedic surgeons, clinicians and scientists.

Collagen Solutions will be primarily highlighting the recent positive data reported for its most advanced regenerative proprietary product, ChondroMimetic(R), an arthroscopic, single-surgery, cost-effective solution for osteochondral defect repair. Earlier this year, the Company announced positive eight year follow-on data for ChondroMimetic(R) demonstrating durable cartilage regeneration in keyhole knee surgery. These results have allowed Collagen Solutions to begin the submission process to re-establish the CE Mark.

Commenting on the conference, Jamal Rushdy, CEO said: "We are delighted to be exhibiting at the pre-eminent ESSKA where we will be showcasing ChondroMimetic(R). This conference will give us the opportunity to actively engage with specialists and potential partners. Being able to demonstrate the key advantages of ChondroMimetic(R) over current therapies within this venue is a key part of our strategy of successfully commercialising ChondroMimetic(R)."

 
  Collagen Solutions Plc                        Tel: [phone] 
   Jamal Rushdy, Chief Executive Officer 
   Hilary Spence, Chief Financial Officer 
   Lisa Baderoon, Head of Investor Relations     Tel: [phone] or [e-mail] 
  Cenkos Securities plc (NOMAD and Broker)      Tel: [phone] 
   Stephen Keys 
   Steve Cox 
  Walbrook PR                                   Tel: [phone] or [e-mail] 
   Anna Dunphy                                   Mob: [phone] 
   Helen Cresswell 
 

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic(R). The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For more information go to: www.collagensolutions.com

What is ESSKA?

ESSKA represents Europe in the fields of degenerative disease and sports medicine. ESSKA achieves this by:

--Bringing together the practitioners: orthopaedic doctors, the surgeons and their various societies

--Fostering research and education, and the exchange of clinical and scientific information

--Organising courses, congresses and fellowship programmes

--Publishing its journals, books and newsletter to keep its members at the forefront of development

In all this, ESSKA's aim is to improve patients' quality-of-life, by improving the quality of their treatment.

For more information go to: www.esska.org

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAUSRKRWOAVRRR

(END) Dow Jones Newswires

May 08, 2018 02:01 ET (06:01 GMT)